ad

Dr Lal PathLabs vs KIMS vs Narayana Health: Which Stock Should You Track

Dr Lal PathLabs PE 58.71, mkt cap Rs 32,077 crore. Krishna Institute of Medical Sciences PE 168.48, mkt cap Rs 32,763 crore. Narayana Hrudayalaya PE 48.09, mkt cap Rs 39,270 crore.


8 Oct 2026 • 11:18 am

Dr Lal PathLabs vs KIMS vs Narayana Health: Which Stock Should You Track

Quick Answer

Dr Lal PathLabs vs Krishna Institute of Medical Sciences vs Narayana Hrudayalaya is a side-by-side comparison of three companies from the Healthcare Providers and Diagnostics space. On this comparison, Dr Lal PathLabs carries a market capitalisation of about Rs 32,077 crore against Rs 32,763 crore for Krishna Institute of Medical Sciences and Rs 39,270 crore for Narayana Hrudayalaya, with return on equity of 20.13%, 10.74% and 17.76% respectively. Each company's numbers are presented here without a declared better pick, since the right stock depends on an investor's own criteria.

Dr Lal PathLabs vs Krishna Institute of Medical Sciences vs Narayana Hrudayalaya starts with the core numbers most investors compare within the Healthcare Providers and Diagnostics segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of October 2026 and will shift with daily price moves.

All three names sit in the Healthcare Providers and Diagnostics bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.

Click Here – Get Free Investment Predictions

Dr Lal PathLabs, Krishna Institute of Medical Sciences and Narayana Hrudayalaya: Company Overview

Dr Lal PathLabs is a listed Indian company in the Healthcare Providers and Diagnostics space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Krishna Institute of Medical Sciences is a listed Indian company in the Healthcare Providers and Diagnostics space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Narayana Hrudayalaya is a listed Indian company in the Healthcare Providers and Diagnostics space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Dr Lal PathLabs vs Krishna Institute of Medical Sciences vs Narayana Hrudayalaya: Valuation and Profitability Snapshot

Metric Dr Lal PathLabs Krishna Institute of Medical Sciences Narayana Hrudayalaya
Market Cap (approx.) Rs 32,077 crore Rs 32,763 crore Rs 39,270 crore
PE Ratio (TTM) 58.71 168.48 48.09
PB Ratio 12.79 8.74 8.65
Return on Equity (ROE) 20.13% 10.74% 17.76%
EPS (TTM, Rs) 32.55 4.63 39.96
Dividend Yield 1.07% 0.00% 0.23%
Debt to Equity 0.08 1.89 1.29
Book Value per Share (Rs) 149.45 89.22 222.08

Check the Univest Screener for Live Data

On valuation, Dr Lal PathLabs trades at a PE of 58.71 and a PB of 12.79, Krishna Institute of Medical Sciences at a PE of 168.48 and a PB of 8.74, while Narayana Hrudayalaya trades at a PE of 48.09 and a PB of 8.65. On return on equity, the three post 20.13%, 10.74% and 17.76% respectively, and on dividend yield they stand at 1.07%, 0.00% and 0.23%.

Dr Lal PathLabs vs Krishna Institute of Medical Sciences vs Narayana Hrudayalaya: Latest Quarterly Results

Company Latest Quarter Revenue Latest Quarter Net Profit YoY Change (Revenue) QoQ Change (Revenue)
Dr Lal PathLabs Rs 829.60 crore Rs 170.50 crore +18.9% +14.2%
Krishna Institute of Medical Sciences Rs 1,195.90 crore Rs 37.40 crore +36.1% +10.3%
Narayana Hrudayalaya Rs 2,719.11 crore Rs 207.27 crore +77.6% +3.7%

Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.

Download the Univest iOS App or Univest Android App to track Dr Lal PathLabs, Krishna Institute of Medical Sciences and Narayana Hrudayalaya live prices.

What Should Investors Look at Beyond These Numbers?

Beyond the metrics above, investors comparing these three healthcare providers and diagnostics names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.

Conclusion

Dr Lal PathLabs vs Krishna Institute of Medical Sciences vs Narayana Hrudayalaya highlights how differently three companies in the same healthcare providers and diagnostics segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information as of October 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Dr Lal PathLabs vs Krishna Institute of Medical Sciences vs Narayana Hrudayalaya

What is the market cap difference between Dr Lal PathLabs, Krishna Institute of Medical Sciences and Narayana Hrudayalaya?

Ans. As of October 2026, Dr Lal PathLabs has a market cap of approximately Rs 32,077 crore, Krishna Institute of Medical Sciences is at approximately Rs 32,763 crore, and Narayana Hrudayalaya is at approximately Rs 39,270 crore.

Which of the three has the highest PE ratio?

Ans. Among Dr Lal PathLabs, Krishna Institute of Medical Sciences and Narayana Hrudayalaya, the PE ratios stand at 58.71, 168.48 and 48.09 respectively as of October 2026.

Which of the three has the highest ROE?

Ans. Dr Lal PathLabs, Krishna Institute of Medical Sciences and Narayana Hrudayalaya post ROE of 20.13%, 10.74% and 17.76% respectively as of October 2026.

Which of these three stocks pays the highest dividend yield?

Ans. Dr Lal PathLabs, Krishna Institute of Medical Sciences and Narayana Hrudayalaya carry dividend yields of 1.07%, 0.00% and 0.23% respectively.

What is the debt to equity ratio for Dr Lal PathLabs, Krishna Institute of Medical Sciences and Narayana Hrudayalaya?

Ans. Dr Lal PathLabs carries a debt to equity of 0.08, Krishna Institute of Medical Sciences of 1.89, and Narayana Hrudayalaya of 1.29.

Which of the three trades at the highest price to book value?

Ans. Dr Lal PathLabs, Krishna Institute of Medical Sciences and Narayana Hrudayalaya trade at price to book ratios of 12.79, 8.74 and 8.65 respectively.

Is one of Dr Lal PathLabs, Krishna Institute of Medical Sciences or Narayana Hrudayalaya better than the others?

Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down